GSK plc Logo

GSK plc

Develops specialty medicines and vaccines to prevent and treat a range of global diseases.

GSK | US

Overview

Corporate Details

ISIN(s):
GB0009252882
LEI:
Country:
United States of America
Address:
79 NEW OXFORD STREET, 0 LONDON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to prevent and treat disease. The company researches, develops, and manufactures a portfolio of specialty medicines and vaccines. Its primary R&D is concentrated in four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. Leveraging advancements in immunology and human genetics, GSK aims to deliver transformative treatments. The company is also committed to expanding global health access by making its products more affordable and available through strategic partnerships and responsible pricing programs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 13:10
Foreign Filer Report
6-K - GSK plc (0001131399) (Filer)
English 62.0 KB

Automate Your Workflow. Get a real-time feed of all GSK plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GSK plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GSK plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Ipsen Logo
Developing innovative medicines for Oncology, Rare Diseases, and Neuroscience.
France IPN
IRLAB Therapeutics Logo
Developing novel drugs for Parkinson's disease and other neurodegenerative CNS disorders.
Sweden IRLAB
IRONWOOD PHARMACEUTICALS INC Logo
Develops and commercializes therapies for GI diseases like IBS-C and chronic constipation.
United States of America IRWD
ISU Abxis Co., Ltd. Logo
Developing antibody-based immunotherapies for oncology and rare diseases.
South Korea 086890
Iterum Therapeutics plc Logo
Develops novel oral & IV anti-infectives to combat multi-drug resistant pathogens.
United States of America ITRM
IVF HARTMANN Holding AG Logo
Produces and distributes medical supplies, wound care, and hygiene items for global healthcare.
Switzerland VBSN
Jade Biosciences, Inc. Logo
Clinical-stage biotech developing therapies for autoimmune and inflammatory diseases.
United States of America JBIO
Jaguar Health, Inc. Logo
Develops plant-based, non-opioid GI therapies for humans and animals.
United States of America JAGX
Janux Therapeutics, Inc. Logo
Developing tumor-activated immunotherapies to treat cancer while minimizing systemic toxicities.
United States of America JANX
Japan Tissue Engineering Co., Ltd. Logo
Pioneers regenerative medicine with tissue products, CDMO services, and research models.
Japan 7774

Talk to a Data Expert

Have a question? We'll get back to you promptly.